Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pareto8020on Oct 16, 2022 10:08am
205 Views
Post# 35027594

RE:JUST FOR LAUGHS! NOT REALLY!

RE:JUST FOR LAUGHS! NOT REALLY!It really is hard to imagine that after years and years of misteps, incompetence and stumbles they finally land that big lucrative contract with a major Pharma for a worldwide exclusive deal (which according to Howard the exclusive should = big $$$) and the price gets driven down to a 52 week low after barely launching from pre-deal levels.  Howie should have at least been able to release some info so the market could evaluate it and adjust SBM's market value accordingly.  But no.....do a major deal and keep everything ultra-secret cause why let the market know what the hell is going on.    

Who's to say the BIG 4 company deal they are doing now for the cat diabetes won't be the same?  I can hear Howard now "well given these 4 major companies want to maintain a competitive advantage in the market details of the deal have to remain confedential - but the deal did put a smile on my face".  

Really we need some fantastic mind blowing results from the anti-aging trial and perhaps that will spark a complete buyout which would be a welcome relief after years of SBM trying to figure out how to run biotech 101.    
<< Previous
Bullboard Posts
Next >>